Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-07
2011-06-07
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S205000
Reexamination Certificate
active
07956075
ABSTRACT:
The invention relates to thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives of general formula (I)wherein Het is thiazole, oxazole, imidazole, isoxazole or isoxazoline, n is an integer from 0 to 6, A is notably selected from various optionally substituted aromatic radicals, B is notably hydrogen, alkyl or phenyl, R1and R2are notably independently hydrogen, alkyl or cycloalkyl and Ω is —NR46R47or —OR48, R46and R47are notably independently hydrogen, alkyl, cycloalkyl or —(CH2)k—COOR51, R51is notably alkyl or haloalkyl and R48is notably hydrogen or alkyl.These compounds have advantageous pharmacological properties which allow their use in therapeutics, notably for treating neurodegenerative disorders or pain.
REFERENCES:
patent: 5137897 (1992-08-01), Throwart et al.
patent: 6586454 (2003-07-01), Chabrier de Lassauniere et al.
patent: 27 02 714 (1978-07-01), None
patent: 4244 (1965-02-01), None
patent: 62 132871 (1987-06-01), None
patent: 52809 (1967-02-01), None
patent: WO 98/58934 (1998-12-01), None
Aruoma, Ros's Free Radical Biology & Medicine, vol. 20, 675-705, Aug. 1995.
Thomas, (1997) Handbook of Synthetic Antioxidants, pp. 1-52, (1997).
Hardman, Front Cover of Mao's Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 9thEdition, pp. 431-519 (1995).
Gould, Int. Journal of Pharm., 33, pp. 201-217, (1986).
Greene, Index from Protective Groups in Organic Synthesis, 2ndEdition, (John Wiley & Sons, Inc. (1991).
Gordon, Bioorganic and Med. Chem. Letters, vol. 3, 915, (1993).
Gordon, Tetrahedron Letters, vol. 34, pp. 1901-1904, (1993).
Malamas, Journal of Medicinal Chemistry, vol. 39, pp. 237-245, (1996).
Reiter, J. Heterocyclic Chem., 24, 927-930, (1987).
Bellamy, Tetrahedron Lett., 25, 8, 839-842, (1984).
Broggini, Synthesis, vol. 9, 1076-1078, (1996).
Ren, Synthetic Communications., 25, (23), 3799-3803 (1995).
Siemeling, Monatshefte fur Chemie, vol. 126, 725-732, (1995).
Moody, Synlett, vol. 9, 1028, (1989).
King, J. Org. Chem., vol. 29, 3459, (1964).
Chiarino, Journal Heterocylic. Chem., 25, 337, (1988).
Ensley, J. of Amer. Chem. Soc., 102, 2838, (1980).
Verbruggen, Bioorganic. Med. Chem. Lett., 6(3), 253-258, (1996).
Mack, J. Med. Chem., 31, 10, 1910-1918, (1988).
Frechet, J. Macromol. Sci. Chem., A11, 3, 507-514, (1977).
Diwu, Tetrahedron Lett., 39, 28, pp. 4987-4990, (1998).
Katritzky, J. Org. Chem., 60, 5638-5642, (1995).
Morton, Tetrahedron Lett., vol. 34, 28, 4481-4484, (1993).
Kim, J. Med. Chem., vol. 17, 369-371, (1974).
Zav'Yalov, Bull. Acd. Sci. Ussr Div. Chem.Sci. (Eng. Tranl.), 29, 1830-1833, (1980).
Asselinj Med. Chem., 29, 6, pp. 1009-1015, (1986).
Ishihara, J. Chem. Soc., Perkin Trans. I, (1992) 24, pp. 3401-3406.
Boy, J. Org. Chem., 59(16), pp. 4482-4489 (1994).
Kawamura, Chem Lett., 9, pp. 931-932, (1998).
Combellas, Synthesis, vol. 8, pp. 788-790, (1993).
Sibi, Syn. Commun., vol. 25(8), pp. 1255-1264, (1995).
Pearson, Tetrahedron Lett. (1999), 40(3), pp. 411-414.
Jenkins, MeLi (J. Med. Chem. (1992), 35(13), 2392-2406.
Buu-Hoi, J. Org. Chem., (1951), 16, 1198-1205.
Kyziol, Tetrahedron (1980), vol. 36, 3017-3019.
Singh, J. Heterocyclic. Chem. (1978), 15, pp. 175-176.
Profft, Arzeimittel Forschung (1962), 12, 48-52.
Wullner, Chem. Commun., (1998), 15, (6), 1509-1510.
Hellwinkel, Chem Ber., (1986), 119, pp. 3165-3197.
Ward, J. Het. Chem. (1990), 27, 1709-1712.
Podlech, Liebigs Ann. Chem. (1995), 1217-1228.
Aoyama, Chem. Pharm. Bull. (1981), 29(11), 3249-3255.
Hird, Chem.Soc., Perkin Trans. 1, (1998), 20, 3479-3484.
Zhang, Tetrahedron Lett., (1996), 37, (26), 4455.
Wityak, J. Med. Chem., (1997), vol. 40, 50-60.
Xue, J. Med. Chem. (1997), vol. 40, pp. 2064-2084.
Collins, J. Med. Chem., (1987), 30, 193-197.
Snider, J. Org. Chem., (1980), 45, 5017-5020.
Yu, J. Med. Chem. (1992), vol. 35, pp. 716-724.
Chan, J. Med. Chem. (1998), vol. 41, pp. 148-156.
Anonymous, Synthesis Alerts (1998), pp. 215-224.
Nordisk, J. Soc. Perkin. Trans. 1 (1998), pp. 351-354.
Izumi, J. Het. Chem. (1993), 30, pp. 1133-1136.
Ikan, Tetrahedron (1967), vol. 23, pp. 3823-3827.
Gilman, J. Amer. Chem. Soc. (1940), vol. 62, pp. 3208-3210.
Anonymous, Zh. Obshch. Khim., (1953), 23, 121-122.
Sasaki, J. Org. Chem., (1974), vol. 39, pp. 1239-1243.
Gilman, J. Amer. Chem. Soc., (1941), 63, pp. 1553-1555.
Plant, J. Chem. Soc. (1934), pp. 1142-1144.
Zelent, Can. J. Chem. Soc. (1982), pp. 945-956.
Massie, J. Org. Chem., (1956), vol. 21, 1006-1008.
Kauffman, J. Heterocyclic.Chem. (1982), vol. 15, pp. 1557-1559.
Gilman, J. Amer. Chem. (1946), 68, pp. 2104.
Winchester, Het. Chem., (1975), 12, pp. 547-549.
Cohen, Syn. Commun., (1982), vol. 12(8), pp. 57-66.
Grisar, J. Med. Chem. (1995), 38(15), pp. 2880-2886.
Cohen, Hely. Chim. Acta., (1978),vol. 61, pp. 837-843.
Meyer, J. Med. Chem., (1997), vol. 40, No. 7, 1049-1062.
Kohno, Biorg. Med. Chem. Lett. (1997), vol. 7, pp. 1519-1524.
Zetterberg, Experimental Cell Research, vol. 43, pp. 517-525, (1966).
Bigg Dennis
Chabrier De Lassauniere Pierre-Etienne
Harnett Jeremiah
Lannoy Jacques
Liberatore Anne-Marie
Anderson Rebecca L
Hunton & Williams LLP
IPSEN Pharma S.A.S.
LandOfFree
Derivatives of heterocycles with 5 members, their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of heterocycles with 5 members, their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of heterocycles with 5 members, their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2737120